Panntherapi
EIC Accelerator Winner From 2023
Pannexin 1 – a novel target for pediatric orphan epilepsy
France
Articles
Panntherapi Secures €12.3 Million from EIC Accelerator to Develop Epilepsy Treatment
FranceEIC Accelerator2023
Read ArticlePannexin 1 – a novel target for pediatric orphan epilepsy